Rabies virus, the prototypical neurotropic virus, causes one of the most lethal zoonotic diseases.
According to official estimates, over 55,000 people die of the disease annually, but this …

Several rabies virus (RV) vaccine strains containing an aspartic acid (Asp) or glutamic acid (Glu)
instead of an arginine (Arg) at position 333 of the RV glycoprotein (G) are apathogenic …

We have previously described the generation of a novel Ebola virus (EBOV) vaccine platform
based on (a) replication-competent rabies virus (RABV), (b) replication-deficient RABV, or (…

To achieve simultaneous measurement of multiple cellular events in molecularly defined
groups of neurons in vivo, we designed a spectrometer-based fiber photometry system that …

The search for a safe and efficacious vaccine for Ebola virus continues, as no current vaccine
candidate is nearing licensure. We have developed (i) replication-competent, (ii) replication…

Late (L) domains containing the highly conserved sequence PPXY were first described for
retroviruses, and later research confirmed their conservation and importance for efficient …

We previously described the generation of a novel Ebola virus (EBOV) vaccine based on
inactivated rabies virus (RABV) containing EBOV glycoprotein (GP) incorporated in the RABV …

The 2013–2016 West African Ebola virus (EBOV) disease outbreak was the largest filovirus
outbreak to date. Over 28 000 suspected, probable, or confirmed cases have been reported, …

The type of immune response induced by a vaccine is a critical factor that determines its
effectiveness in preventing infection or disease. Inactivated and live rabies virus (RV) vaccine …

Although current postexposure prophylaxis rabies virus (RV) vaccines are effective, ∼40,000–70,000
rabies-related deaths are reported annually worldwide. The development of …